Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Gajewski

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Polish Archives of Internal Medicine|September 21, 2023
Avoiding medical futility in patients dying in a hospital: a position statement of the Polish Society of Internal Medicine Working Group on Medical Futility at Internal Medicine Units. Part 1: A dying patient who is not legally incapacitated but is incapable of making informed decisions regarding treatment that is considered medically futileWojciech Szczeklik, Małgorzata Krajnik, Jakub Pawlikowski, et al.
Journal of Clinical Medicine|October 14, 2022
COVID-19 Related Myocarditis in Adults: A Systematic Review of Case ReportsSzymon Urban, Michał Fułek, Mikołaj Błaziak, et al.
European Journal of Heart Failure|May 1, 2021
Surgical ablation of the right greater splanchnic nerve for the treatment of heart failure with preserved ejection fraction: first-in-human clinical trialFilip Málek, Piotr Gajewski, Robert Zymliński, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 25, 2009
2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatientsRoman Jaeschke, Piotr Gajewski, Shannon M Bates, et al.
Kardiologia Polska|January 8, 2025
National Cardiogenic Shock Treatment Program in PolandRobert J Gil, Piotr Gajewski, Tomasz Pawłowski, et al.
ESC Heart Failure|October 8, 2024
Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trialJan Biegus, Alexander Mebazaa, Marco Metra, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 1, 2025
Safety and efficacy intravenous istaroxime up to 60 hours for patients with pre-cardiogenic shockJan Biegus, Alexandre Mebazaa, Marco Metra, et al.
ESC Heart Failure|October 14, 2025
Haemodynamic effects of istaroxime in SCAI stage B HF-related cardiogenic shock: Insights from the SEISMiC trialMatteo Pagnesi, Gad Cotter, Beth Davison, et al.
Kardiologia Polska|May 14, 2025
First SHOCK-TEAM in Poland: Single hub center experience with multidisciplinary care for cardiogenic shockWiktor Kuliczkowski, Mikołaj Błaziak, Roman Przybylski, et al.
Scientific Reports|October 20, 2023
Sex-stratified patterns of emergency cardiovascular admissions prior and during the COVID-19 pandemicPiotr Gajewski, Mikołaj Błaziak, Szymon Urban, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Polish Archives of Internal Medicine|September 21, 2023
Avoiding medical futility in patients dying in a hospital: a position statement of the Polish Society of Internal Medicine Working Group on Medical Futility at Internal Medicine Units. Part 1: A dying patient who is not legally incapacitated but is incapable of making informed decisions regarding treatment that is considered medically futileWojciech Szczeklik, Małgorzata Krajnik, Jakub Pawlikowski, et al.
Journal of Clinical Medicine|October 14, 2022
COVID-19 Related Myocarditis in Adults: A Systematic Review of Case ReportsSzymon Urban, Michał Fułek, Mikołaj Błaziak, et al.
European Journal of Heart Failure|May 1, 2021
Surgical ablation of the right greater splanchnic nerve for the treatment of heart failure with preserved ejection fraction: first-in-human clinical trialFilip Málek, Piotr Gajewski, Robert Zymliński, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 25, 2009
2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatientsRoman Jaeschke, Piotr Gajewski, Shannon M Bates, et al.
Kardiologia Polska|January 8, 2025
National Cardiogenic Shock Treatment Program in PolandRobert J Gil, Piotr Gajewski, Tomasz Pawłowski, et al.
ESC Heart Failure|October 8, 2024
Safety and efficacy of up to 60 h of iv istaroxime in pre-cardiogenic shock patients: Design of the SEISMiC trialJan Biegus, Alexander Mebazaa, Marco Metra, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 1, 2025
Safety and efficacy intravenous istaroxime up to 60 hours for patients with pre-cardiogenic shockJan Biegus, Alexandre Mebazaa, Marco Metra, et al.
ESC Heart Failure|October 14, 2025
Haemodynamic effects of istaroxime in SCAI stage B HF-related cardiogenic shock: Insights from the SEISMiC trialMatteo Pagnesi, Gad Cotter, Beth Davison, et al.
Kardiologia Polska|May 14, 2025
First SHOCK-TEAM in Poland: Single hub center experience with multidisciplinary care for cardiogenic shockWiktor Kuliczkowski, Mikołaj Błaziak, Roman Przybylski, et al.
Scientific Reports|October 20, 2023
Sex-stratified patterns of emergency cardiovascular admissions prior and during the COVID-19 pandemicPiotr Gajewski, Mikołaj Błaziak, Szymon Urban, et al.
Pageof 8